PET Pharm Biotech Co., Ltd. manufactures molecular imaging medicines. Its products include Naolixi Injection, FDG Fluodeoxy glucose Injection, Sodium fluoride injection and Radioactive sodium iodide capsules. The company was founded on October 01, 2011 and is headquartered in New Taipei city, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company